Semler Scientific (SMLR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
36.86 -0.06 (-0.16%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 35.03 -1.83 (-4.96%) 16:45 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 40,899 | 20,583 | 14,325 | 17,222 | 14,007 |
Depreciation Amortization | 579 | 599 | 589 | 628 | 576 |
Income taxes - deferred | 5,727 | -664 | -351 | 408 | 2,136 |
Accounts receivable | 1,844 | -2,508 | -367 | -874 | 623 |
Accounts payable and accrued liabilities | -262 | -433 | 392 | -234 | 339 |
Other Working Capital | 1,194 | -3,738 | 1,670 | -4,578 | -1,730 |
Other Operating Activity | -25,571 | 7,491 | 1,205 | 3,484 | -837 |
Operating Cash Flow | $24,410 | $21,330 | $17,463 | $16,056 | $15,114 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -500 | 19,224 | -24,675 | N/A | N/A |
PPE Investments | -189,482 | -828 | -2,160 | -825 | -758 |
Purchase Of Investment | N/A | N/A | N/A | N/A | -2,190 |
Sale Of Investment | N/A | N/A | N/A | N/A | 1,942 |
Investing Cash Flow | $-189,982 | $18,396 | $-26,835 | $-825 | $-1,006 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 121,066 | -1,898 | 168 | 58 | 230 |
Common Stock Repurchased | N/A | N/A | -4,991 | 0 | N/A |
Other Financing Activity | -3,874 | -3,510 | -114 | -45 | 0 |
Financing Cash Flow | $117,192 | $-5,408 | $-4,937 | $13 | $230 |
Beginning Cash Position | 57,332 | 23,014 | 37,323 | 22,079 | 7,741 |
End Cash Position | 8,952 | 57,332 | 23,014 | 37,323 | 22,079 |
Net Cash Flow | $-48,380 | $34,318 | $-14,309 | $15,244 | $14,338 |
Free Cash Flow | |||||
Operating Cash Flow | 24,410 | 21,330 | 17,463 | 16,056 | 15,114 |
Capital Expenditure | -189,751 | -345 | -2,160 | -825 | -758 |
Free Cash Flow | -165,341 | 20,985 | 15,303 | 15,231 | 14,356 |